Look to JAV for a company in health care with a sure winner but no remaining money. Not an unlikely outcome: take-out at a price above market but well below what holders would like. And all stock. I'd GUESS $0.40-0.50 nominal value.
Since there aren't really any third-line diversified medical equipment suppliers left in the US, I'd expect a European buyer. This could take some time. (The easiest way to do it might be a management LBO followed by private sale--I think Avaya did that a couple years ago if anyone wants to look at mechanics).
I agree. The takeout price will likely be at some premium to the exercise price of management options which is .26. .40 or .50 is not unreasonable. I think it would be more attractive to a European buyer given that it has EU approval and some distribution. I am not convinced that RG is a sure winner. The kit/console numbers don't give me much confidence.
it maybe could be but so could refinancing............shareholders could still be deluted extremely either way imo. a partner will want a big piece of pie imo. and plc is in no position to negotiate imo. it will be a take it or leave it deal